Sakar Healthcare Limited
Incorporated in 2004, Sakar Healthcare Ltd is in the business of manufacturing Research & Development of Pharmaceutical products
What Sakar files
- Others33
- Updates18
- Board Meeting16
- Investor Meet15
- Important15
- Results4
Sakar Healthcare delivered strong Q1FY27 results, with revenue jumping 38% YoY to ₹72.97 Cr, fueled by new oncology product authorizations and robust demand. Profit After Tax (PAT) surged 120% YoY to ₹10.28 Cr, with Basic EPS at ₹4.62. EBITDA grew 67% YoY to ₹21.25 Cr, achieving 29% margins. The company's...
Sakar Healthcare reported strong financial performance for the quarter and full fiscal year ended March 31, 2026. **1. Business Performance:** Revenue for the quarter rose 42% YoY to ₹71.10 Cr, with full-year revenue also growing 42% to ₹251.74 Cr. Profitability saw significant improvement; Q4 EBITDA jumped 67% to ₹26.24 Cr...
Here's a concise, retail-friendly summary in the style of an equity analyst for Twitter: **1. Business Performance:** API-integrated Sakar Healthcare delivered strong Q3FY26 results. Its diversified model, driven by CDMO and own brand exports, is gaining momentum, with oncology emerging as a key growth engine. **2. Growth Drivers or Strategy:**...